Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products
2012年7月6日 更新者:McNeil AB
Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
Multiple-dose nicotine pharmacokinetics with three oral nicotine replacement products.
A study in healthy smokers.
研究概览
详细说明
Fifty (50) healthy male or female subjects between the ages of 19 and 50 years, inclusive, smoking at least 20 cigarettes daily during at least one year preceding inclusion.
Multiple doses of all study treatments are given either every 60 minutes or every 90 minutes, respectively.
All products will be administered in accordance with labeling, on five separate treatment visits.
The subjects will abstain from smoking from 8 pm in the evening before and until the end of each visit.
研究类型
介入性
注册 (实际的)
50
阶段
- 阶段1
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Lund、瑞典、SE-222 20
- McNeil AB Clinical Pharmacology R&D
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
19年 至 50年 (成人)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Healthy subjects, smoking at least 20 cigarettes daily during at least one year preceding inclusion.
- BMI between 17.5 and 30.0 kg/m2 and a total body weight of at least 55.0 kg.
- Female participants of child-bearing potential are required to use a medically acceptable means of birth control.
- A personally signed and dated informed consent document, indicating that the subject has been informed of all pertinent aspects of the study.
- Willing and able to comply with all scheduled visits and study procedures
Exclusion Criteria:
- Pregnancy, lactation or intended pregnancy.
- Treatment with an investigational product or donation or loss of blood within 3 month preceding the first dose of study medication.
- Any medical condition or history that might, per protocol or in the opinion of the investigator, compromise subject safety or trial results.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:NRT 60
A 6 mg dose of an experimental Nicotine Replacement Therapy (NRT) given every hour for 11 hours, with a 36-hour washout between visits
|
6 mg experimental Nicotine Replacement Therapy (NRT)
其他名称:
4 mg marketed Nicotine Fruit Gum (NFG)
其他名称:
4 mg marketed nicotine mint lozenge (NIQ)
其他名称:
|
|
有源比较器:NFG 60
A 4 mg dose of a marketed Nicotine Fruit Gum (NFG) given every hour for 11 hours, with a 36-hour washout between visits
|
6 mg experimental Nicotine Replacement Therapy (NRT)
其他名称:
4 mg marketed Nicotine Fruit Gum (NFG)
其他名称:
4 mg marketed nicotine mint lozenge (NIQ)
其他名称:
|
|
实验性的:NRT 90
A 6 mg dose of NRT given every 90 minutes for 10.5 hours, with a 36-hour washout between visits
|
6 mg experimental Nicotine Replacement Therapy (NRT)
其他名称:
4 mg marketed Nicotine Fruit Gum (NFG)
其他名称:
4 mg marketed nicotine mint lozenge (NIQ)
其他名称:
|
|
有源比较器:NFG 90
A 4 mg dose of NFG given every 90 minutes for 10.5 hours, with a 36-hour washout between visits
|
6 mg experimental Nicotine Replacement Therapy (NRT)
其他名称:
4 mg marketed Nicotine Fruit Gum (NFG)
其他名称:
4 mg marketed nicotine mint lozenge (NIQ)
其他名称:
|
|
有源比较器:NIQ 60
A 4 mg dose of marketed nicotine mint lozenge (NIQ), given every hour for 11 hours, with a 36-hour washout between visits
|
6 mg experimental Nicotine Replacement Therapy (NRT)
其他名称:
4 mg marketed Nicotine Fruit Gum (NFG)
其他名称:
4 mg marketed nicotine mint lozenge (NIQ)
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maximum Observed Plasma Concentration
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Maximum Observed Plasma Concentration (Cmax), which is the maximum (peak) concentration (amount of drug) measurable in blood plasma within the last dosing interval, measured in nanograms/milliliter (ng/mL)
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
|
Average Concentration
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Average Nicotine Plasma Concentration (Cav) within the last dosing interval
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
|
Area Under the Curve
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Area under the nicotine plasma concentration-vs.-time
curve during the last dosing interval (AUCt)
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
最大浓度时间
大体时间:给药后 12 小时内
|
达到最大浓度的时间 (Tmax)
|
给药后 12 小时内
|
|
Minimum Observed Concentration
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Minimum Observed Plasma Concentration (Cmin), which is the minimum concentration (amount of drug) measurable in blood plasma within the last dosing interval, measured in nanograms/milliliter (ng/mL)
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
|
Peak-Trough Fluctuation
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Percent of Peak-Trough Fluctuation in one dosing interval at steady state (PTF)
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
|
Swing
大体时间:within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
Swing in one dosing interval at steady state, calculated as (Cmax-Cmin)/ Cmin
|
within the last dosing interval (starting at 10.5-11 hours after first product administration)
|
|
Nicotine Released
大体时间:30 minutes
|
The amount of nicotine released from the product during product administration
|
30 minutes
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
赞助
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2011年2月1日
初级完成 (实际的)
2011年5月1日
研究完成 (实际的)
2011年6月1日
研究注册日期
首次提交
2011年3月22日
首先提交符合 QC 标准的
2011年3月23日
首次发布 (估计)
2011年3月24日
研究记录更新
最后更新发布 (估计)
2012年7月10日
上次提交的符合 QC 标准的更新
2012年7月6日
最后验证
2012年7月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.